These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37754772)

  • 1. The impact of Parkinson's disease-associated gut microbiota on the transcriptome in
    Liu X; Yang M; Liu R; Zhou F; Zhu H; Wang X
    Microbiol Spectr; 2023 Sep; 11(5):e0017623. PubMed ID: 37754772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
    Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
    Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in fecal microbiota transplantation for treatment of Parkinson's disease].
    Zhang M; Wang H; Xue L; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3812-3819. PubMed ID: 34841786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease.
    Yu J; Meng J; Qin Z; Yu Y; Liang Y; Wang Y; Min D
    J Neuroinflammation; 2023 May; 20(1):117. PubMed ID: 37208728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An altered microbiome in a Parkinson's disease model Drosophila melanogaster has a negative effect on development.
    Parker-Character J; Hager DR; Call TB; Pickup ZS; Turnbull SA; Marshman EM; Korch SB; Chaston JM; Call GB
    Sci Rep; 2021 Dec; 11(1):23635. PubMed ID: 34880269
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-β-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota-gut-brain axis.
    Sun X; Feng S; Qin B; Ye J; Xie L; Gui J; Sang M
    Food Funct; 2024 Feb; 15(3):1489-1512. PubMed ID: 38227477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
    Dong S; Sun M; He C; Cheng H
    Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota-Induced Modulation of the Central Nervous System Function in Parkinson's Disease Through the Gut-Brain Axis and Short-Chain Fatty Acids.
    Ni Y; Tong Q; Xu M; Gu J; Ye H
    Mol Neurobiol; 2024 Aug; ():. PubMed ID: 39134825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease.
    Yang X; Qian Y; Xu S; Song Y; Xiao Q
    Front Aging Neurosci; 2017; 9():441. PubMed ID: 29358918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in mice.
    Wei N; Ju M; Su X; Zhang Y; Huang Y; Rao X; Cui L; Lin Z; Dong Y
    Schizophrenia (Heidelb); 2024 Apr; 10(1):44. PubMed ID: 38589422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway.
    Jia X; Chen Q; Zhang Y; Asakawa T
    Front Cell Infect Microbiol; 2023; 13():1296713. PubMed ID: 38173790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease.
    Xu Y; Xie M; Xue J; Xiang L; Li Y; Xiao J; Xiao G; Wang HL
    FASEB J; 2020 Apr; 34(4):5931-5950. PubMed ID: 32157731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
    Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
    Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Microbiome and Microbiota-Derived Sodium Butyrate on
    Zhou F; Liu B; Liu X; Li Y; Wang L; Huang J; Luo G; Wang X
    Metabolites; 2021 May; 11(5):. PubMed ID: 34066348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.